|Articles|October 26, 2021
Chiral Purity Testing of the Drug Substance Rivaroxaban Using a Chiral Column as per USP Monograph
Author(s)Phenomenex, Inc.
The successful enantiomeric separation is demonstrated between rivaroxaban and its enantiomer impurity, R enantiomer, using the Lux® 5 µm Cellulose-1 Chiral HPLC column.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Related Content
Trending on LCGC International
1
Navigating Adverse Reactions in GLP-1 Treatment
2
Decoding Sweet Potato Drought Resilience: Metabolomic Evidence from UPLC-MS Profiling
3
Toward Safer Diabetes Devices: GC–MS Detection of Allergens in Sensors, Pumps, and Infusion Sets
4
Advancing RNA-Based Therapeutics: IQ Consortium Experts on Optimizing Chromatographic Bioanalysis
5
